0001209191-17-026567.txt : 20170411 0001209191-17-026567.hdr.sgml : 20170411 20170411161928 ACCESSION NUMBER: 0001209191-17-026567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170410 FILED AS OF DATE: 20170411 DATE AS OF CHANGE: 20170411 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siegel Eric H. CENTRAL INDEX KEY: 0001527573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 17756113 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY RD., BLDG. E336 STREET 2: C/O INCYTE CORP., EXPERIMENTAL STATION CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-10 0 0000879169 INCYTE CORP INCY 0001527573 Siegel Eric H. 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, General Counsel Common Stock 2017-04-10 4 M 0 2223 18.32 A 19008 D Common Stock 2017-04-10 4 M 0 1820 64.55 A 20828 D Common Stock 2017-04-10 4 S 0 2223 140.18 D 18605 D Common Stock 2017-04-10 4 S 0 1820 140.18 D 16785 D Non-Qualified Stock Option (right to buy) 18.32 2017-04-10 4 M 0 2223 0.00 D 2020-02-08 Common Stock 2223 0 D Non-Qualified Stock Option (right to buy) 64.55 2017-04-10 4 M 0 1820 0.00 D 2021-01-20 Common Stock 1820 22032 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Eric Siegel 2017-04-11